case_images: PMC11256239_01
case_images: Resistance of Salmonella strains against: (A) co-amoxiclav, ampicillin, chloramphenicol, ceftazidime, cefixime, and ciprofloxacin; (B) ceftriaxone, cefoperazone/sulbactam, co-trimoxazole, and piperacillin/tazobactam. The bars present the number of cases with resistant, sensitive, and intermediately sensitive strains against the mentioned antibiotics. Reprinted from Figures 2 and 3 in "Emerging trends of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Salmonella typhi in a tertiary care hospital of Lahore, Pakistan" by, licensed under Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
case_images: fmicb-15-1381511-g003.jpg
case_images: PMC11256239_01_fmicb-15-1381511-g003.jpg
case_images: fig3
case_images: Figure 3 deficits the resistance pattern exhibited by Salmonella strains as reported by.
case_images: Antimicrobial profiles of carbapenem-resistant Klebsiella pneumoniae isolates as reported by. Reprinted from Figure 1 in "The molecular characterization of nosocomial carbapenem-resistant Klebsiella pneumoniae co-Harboring blaNDM and blaOXA-48 in Jeddah" by, licensed under Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
case_images: fmicb-15-1381511-g004.jpg
case_images: PMC11256239_01_fmicb-15-1381511-g004.jpg
case_images: fig4
case_images: OXA-48 may have become endemic in Saudi Arabian hospitals, as evidenced by the high prevalence of the pathogen among K. pneumoniae isolates found in the current study (Figure 4).
case_images: (A) A summary of events in the AMR timeline. (B) Timeline illustrates antibiotics evolution. (A) Reprinted from Figure 1 in "A new era of antibiotics: the clinical potential of antimicrobial peptides" by, licensed under Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). (B) Reprinted from Figure 1 in "Antimicrobial resistance and recent alternatives to antibiotics for the control of bacterial pathogens with an emphasis on foodborne pathogens" by, licensed under Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
case_images: fmicb-15-1381511-g005.jpg
case_images: PMC11256239_01_fmicb-15-1381511-g005.jpg
case_images: fig5
case_images: As a result, the pharmaceutical industry's R&D stream is running down of innovative drugs (Figure 5).